Načítá se...
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
BACKGROUND: Despite intensive treatment regimens, the outcome of Mycobacterium abscessus infections is extremely poor and thus novel treatment regimens are needed. Although tigecycline seems to be one of the best options currently available, its long-term use is hampered by severe toxic side effects...
Uloženo v:
| Vydáno v: | J Antimicrob Chemother |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183808/ https://ncbi.nlm.nih.gov/pubmed/31236595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz267 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|